Abstract
Pemphigus vulgaris is a severe autoimmune disease diagnosed by painful erosions and extensive blistering of the skin and mucous membranes. Autoantibodies against epicutaneous antigens cause the blisters and erosions in pemphigus vulgaris. Among them, antigens such as desmoglein 1 and 3 are of particular importance. The aim of the author’s study was to determine the relationship between the levels of autoantibodies against desmoglein 1 and 3, using the enzyme-linked immunosorbent assay (ELISA) method in patients newly diagnosed with pemphigus vulgaris, and timeline of the disease among the patients hospitalized in Razi Hospital, Tehran, Iran, during 2013–2014.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Chams-Davatchi C, Rahbar Z, Daneshpazhooh M, Mortazavizadeh SMA, Akhyani M, Esmaili N, et al. Pemphigus vulgaris activity score and assessment of convergent validity. Acta Med Iran. 2013;51(4):224–30.
Chams-Davatchi C, Valikhani M, Daneshpazhooh M, Esmaili N, Balighi K, Hallaji Z, et al. Pemphigus: analysis of 1209 cases. Int J Dermatol. 2005;44(6):470–6.
Meyer N, Misery L. Geoepidemiologic considerations of auto-immune pemphigus. Autoimmun Rev. 2010;9(5):A379–A82.
Nagel A, Lang A, Engel D, Podstawa E, Hunzelmann N, de Pita O, et al. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3. Clin Immunol. 2010;134(3):320–30.
Hertl M. Humoral and cellular autoimmunity in autoimmune bullous skin disorders. Int Arch Allergy Immunol. 2000;122(2):91–100.
Chams-Davatchi C. Prevalence and treatment of pemphigus in Iran. Dermatol Clin. 2011;29(4):681–3.
Daneshpazhooh M, Chams-Davatchi C, Payandemehr P, Nassiri S, Valikhani M, Safai-Naraghi Z. Spectrum of autoimmune bullous diseases in Iran: a 10-year review. Int J Dermatol. 2012;51(1):35–41.
Ramos W, Chacon GR, Galarza C, Gutierrez EL, Smith ME, Ortega-Loayza AG. Endemic pemphigus in the Peruvian Amazon: epidemiology and risk factors for the development of complications during treatment. An Bras Dermatol. 2012;87(6):838–45.
Savin J. Some factors affecting prognosis in pemphigus vulgaris and pemphigoid. Br J Dermatol. 1981;104(4):415–20.
Carson PJ, Hameed A, Ahmed AR. Influence of treatment on the clinical course of pemphigus vulgaris. J Am Acad Dermatol. 1996;34(4):645–52.
Mehta JN, Martin AG. A case of pemphigus vulgaris improved by cigarette smoking. Arch Dermatol. 2000;136(1):15–7.
Valikhani M, Kavusi S, Chams-Davatchi C, Daneshpazhooh M, Barzegari M, Ghiasi M, et al. Pemphigus and associated environmental factors: a case–control study. Clin Exp Dermatol. 2007;32(3):256–60.
Valikhani M, Kavusi S, Chams-Davatchi C, Hallaji Z, Esmaili N, Ghandi N, et al. Impact of smoking on pemphigus. Int J Dermatol. 2008;47(6):567–70.
Saha M, Bhogal B, Black M, Cooper D, Vaughan R, Groves R. Prognostic factors in pemphigus vulgaris and pemphigus foliaceus. Br J Dermatol. 2014;170(1):116–22.
Herbst A, Bystryn JC. Patterns of remission in pemphigus vulgaris. J Am Acad Dermatol. 2000;42(3):422–7.
Seidenbaum M, David M, Sandbank M. The course and prognosis of pemphigus. A review of 115 patients. Int J Dermatol. 1988;27(8):580–4.
Kavusi S, Daneshpazhooh M, Farahani F, Abedini R, Lajevardi V, Chams-Davatchi C. Outcome of pemphigus vulgaris. J Eur Acad Dermatol Venereol. 2008;22(5):580–4.
Venugopal SS, Murrell DF. Diagnosis and clinical features of pemphigus vulgaris. Dermatol Clin. 2011;29(3):373–80.
Harman K, Gratian M, Bhogal B, Challacombe S, Black M. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype. Br J Dermatol. 2000;143(2):343–8.
Patsatsi A, Kyriakou A, Giannakou A, Pavlitou-Tsiontsi A, Lambropoulos A, Sotiriadis D. Clinical significance of anti-desmoglein-1 and -3 circulating autoantibodies in pemphigus patients measured by area index and intensity score. Acta Derm Venereol. 2014;94(2):203–6.
Murrell DF, Dick S, Ahmed AR, Amagai M, Barnadas MA, Borradori L, et al. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus. J Am Acad Dermatol. 2008;58:1043–6.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Mohammad Beigi, P.K. (2018). Clinical Research Introduction. In: A Clinician's Guide to Pemphigus Vulgaris. Springer, Cham. https://doi.org/10.1007/978-3-319-67759-0_10
Download citation
DOI: https://doi.org/10.1007/978-3-319-67759-0_10
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-67758-3
Online ISBN: 978-3-319-67759-0
eBook Packages: MedicineMedicine (R0)